P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)

por Kowanetz, M, Vu, MT, Wu, J, Koeppen, H, Kohrt, H, Gettinger, S, Cruz, C, Denker, M, Chen, DS, Hegde, P
Publicado 2014